Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis (Q44353700)
Jump to navigation
Jump to search
scientific article published on 6 March 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis |
scientific article published on 6 March 2003 |
Statements
1 reference
Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis (English)
1 reference
1 reference
Susan Branford
1 reference
Zbigniew Rudzki
1 reference
Sonya Walsh
1 reference
Ian Parkinson
1 reference
Andrew Grigg
1 reference
Kerry Taylor
1 reference
Richard Herrmann
1 reference
John F Seymour
1 reference
Chris Arthur
1 reference
David Joske
1 reference
Kevin Lynch
1 reference
Tim Hughes
1 reference
6 March 2003
1 reference
Identifiers
1 reference